Usage: Assist to reduce pain and inflammation associated with arthritis and sports injury. Higher dosages may be used for fibromyalgia and neuralgia under doctor's supervision.
In human studies, Palmitoyethanolamide (PEA) has been clinically demonstrated to relieve symptoms of pain and inflammation associated with arthritis, migraines and sports injury. PEA acts on many different pathways, one of which is the inactivation of the cannabinoid receptors 1 and 2 (CB1 and CB2), giving rise to its analgesic properties without adverse effects such as addiction and sedation.
Jesik PEA 400mg capsules is scientifically formulated using micronised Palmitoyethanolamide dispersed in CapsuleBlend™ to enhance its bioavailability compared to standard PEA.
How PEA Works
The function of PEA is remarkably extensive. PEA acts on many different pathways, one of which is the inactivation of the cannabinoid receptors 1 and 2 (CB1 and CB2) owing to its analgesic effects. PEA has been clinically demonstrated to relieve symptoms of pain and inflammation associated with arthritis, migraines and sports injury. Higher doses have also been shown to be helpful in neuropathic pain.
Dosing
Take as directed by your physician. Dosage will vary depending on your intended use. The standard maintenance dose for arthritis is 1200mg.
Ingredients
Active: Micronised Palmitoyethanolamide 400mg
Inactive: CapsuleBlend (improves absorption) is free from dairy, lactose, gluten, artificial flavours and colours.
Storage
Store in a cool, dry place below 25 degrees Celsius.
